Download the White Paper How BNCT will improve outcomes for the most difficult-to-treat cancers   Aggressive cancers like glioblastoma remain lethal due to collateral damage from conventional surgery and radiation. Boron Neutron Capture Therapy (BNCT) offers a breakthrough: pairing non-toxic boron-10 drugs with low-intensity radiation to destroy cancer at the

Download the White Paper Advancing Beyond Conventional Cancer Treatments:Why Novel Therapies Are Critical to Continued Progress in Cancer Care Dramatic advances in cancer treatment have completely transformed the landscape of cancer care in the last several decades. Yet, as the treatment outlook continues to improve for the preponderance of cancer

TAE Life Sciences is developing a next-generation boron neutron capture therapy for cancer. After recently introducing Alphabeam, a compact and affordable accelerator-based neutron system suitable for hospital settings, the company is now focusing on the development of novel boron drugs with improved tumor selectivity and increased 10B loads. TAE Life